Novo Nordisk A/S announced a share repurchase program on May 6, 2024, with plans to buy back up to DKK 2.2 billion in B shares from May 7 to August 5, 2024; as of May 24, 2024, they have repurchased a total of 9,170,402 B shares at an average price of DKK 864.18 per share.